Wells Fargo & Company »

Protagonist Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $371k 16k 22.93
2023-09-30 $1.3M 77k 16.68
2023-06-30 $2.0M 71k 27.62
2022-12-31 $403 37 10.92
2022-09-30 $19k 2.3k 8.26
2022-06-30 $48k 5.6k 8.59
2022-03-31 $616k 26k 23.67
2021-12-31 $1.4M 40k 33.87
2021-09-30 $1.1M 59k 18.00
2021-06-30 $1.3M 30k 44.88
2021-03-31 $995k 38k 25.89
2020-12-31 $1.5M 74k 20.16
2020-09-30 $514k 26k 19.58
2020-06-30 $268k 15k 17.90
2020-03-31 $344k 49k 7.08
2019-12-31 $237k 34k 7.09
2019-09-30 $313k 26k 12.03
2019-06-30 $249k 21k 12.10
2019-03-31 $205k 16k 12.54
2018-12-31 $123k 18k 6.72
2018-09-30 $130k 13k 10.34
2018-06-30 $88k 13k 6.68
2018-03-31 $73k 8.5k 8.54
2017-12-31 $115k 5.5k 20.87
2017-06-30 $67k 5.9k 11.30
2017-03-31 $67k 5.2k 12.84
2016-12-31 $115k 5.2k 22.03